In fact, Inoue and colleagues showed that re-expression of ARID1A in a breast cancer cell line augments transcriptional activation through glucocorticoid receptors, estrogen receptor, and androgen receptor (Inoue et al., 2002). The gene discussed is ARID1A; the disease is breast cancer.